|
C13ORF27 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.284400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.238000E-01 |
| Normal-vs-Stage2 |
6.551000E-01 |
| Normal-vs-Stage3 |
8.881200E-01 |
| Normal-vs-Stage4 |
2.818300E-02 |
| Stage1-vs-Stage2 |
5.142800E-01 |
| Stage1-vs-Stage3 |
6.760800E-01 |
| Stage1-vs-Stage4 |
1.932310E-02 |
| Stage2-vs-Stage3 |
7.228400E-01 |
| Stage2-vs-Stage4 |
1.164000E-01 |
| Stage3-vs-Stage4 |
3.987700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.769400E-01 |
| Normal-vs-AfricanAmerican |
6.721800E-01 |
| Normal-vs-Asian |
8.147400E-01 |
| Caucasian-vs-AfricanAmerican |
3.740800E-01 |
| Caucasian-vs-Asian |
7.137600E-01 |
| AfricanAmerican-vs-Asian |
9.921600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.638400E-01 |
| Normal-vs-Female |
5.564800E-01 |
| Male-vs-Female |
9.310800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.240200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.917850E-01 |
| Normal-vs-Age(61-80Yrs) |
9.186600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.154400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.344700E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.912300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.771900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.601400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.640000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.076200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.382800E-01 |
| Normal-vs-Grade 2 |
9.661800E-01 |
| Normal-vs-Grade 3 |
7.035900E-02 |
| Normal-vs-Grade 4 |
7.768400E-01 |
| Grade 1-vs-Grade 2 |
4.237000E-01 |
| Grade 1-vs-Grade 3 |
2.196800E-01 |
| Grade 1-vs-Grade 4 |
3.400000E-01 |
| Grade 2-vs-Grade 3 |
8.021900E-02 |
| Grade 2-vs-Grade 4 |
7.926200E-01 |
| Grade 3-vs-Grade 4 |
5.133400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.399800E-03 |
| Normal-vs-ccB subtype |
1.441050E-04 |
| ccA subtype-vs-ccB subtype |
1.23399956919457E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.456000E-01 |
| Normal-vs-N1 |
9.510200E-01 |
| N0-vs-N1 |
9.230600E-01 |
|
|
